BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22500694)

  • 41. Different amplification patterns of the human telomerase RNA gene in invasive cervical carcinomas and cervical intraepithelial neoplasia grade III.
    Xiang L; Yang H; Li J; Wu X; Zhou X
    Diagn Cytopathol; 2012 Oct; 40(10):849-55. PubMed ID: 21381227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical significance of hTERC gene amplification detection by FISH in the screening of cervical lesions.
    Zhang Y; Wang X; Ma L; Wang Z; Hu L
    J Huazhong Univ Sci Technolog Med Sci; 2009 Jun; 29(3):368-71. PubMed ID: 19513624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MYC and human telomerase gene (TERC) copy number gain in early-stage non-small cell lung cancer.
    Flacco A; Ludovini V; Bianconi F; Ragusa M; Bellezza G; Tofanetti FR; Pistola L; Siggillino A; Vannucci J; Cagini L; Sidoni A; Puma F; Varella-Garcia M; Crinò L
    Am J Clin Oncol; 2015 Apr; 38(2):152-8. PubMed ID: 25806711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increase in viral load, viral integration, and gain of telomerase genes during uterine cervical carcinogenesis can be simultaneously assessed by the HPV 16/18 MLPA-assay.
    Theelen W; Speel EJ; Herfs M; Reijans M; Simons G; Meulemans EV; Baldewijns MM; Ramaekers FC; Somja J; Delvenne P; Hopman AH
    Am J Pathol; 2010 Oct; 177(4):2022-33. PubMed ID: 20813962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fluorescence in situ hybridization testing for the diagnosis of high-grade cervical abnormalities: a systematic review.
    Earley A; Lamont JL; Dahabreh IJ; Cowan J; Feldman S; Uhlig K
    J Low Genit Tract Dis; 2014 Jul; 18(3):218-27. PubMed ID: 24477173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MiRNA detection in cervical exfoliated cells for missed high-grade lesions in women with LSIL/CIN1 diagnosis after colposcopy-guided biopsy.
    Ye J; Cheng XD; Cheng B; Cheng YF; Chen XJ; Lu WG
    BMC Cancer; 2019 Jan; 19(1):112. PubMed ID: 30700264
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Promoter hypermethylation analysis of host genes in cervical intraepithelial neoplasia and cervical cancers on histological cervical specimens.
    Shi L; Yang X; He L; Zheng C; Ren Z; Warsame JA; Suye S; Yan L; Cai H; Xiao X; Fu C
    BMC Cancer; 2023 Feb; 23(1):168. PubMed ID: 36803573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genomic amplification of HPV, h-TERC and c-MYC in liquid-based cytological specimens for screening of cervical intraepithelial neoplasia and cancer.
    Ji W; Lou W; Hong Z; Qiu L; Di W
    Oncol Lett; 2019 Feb; 17(2):2099-2106. PubMed ID: 30675277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Amplification and clinical significance of hTERC gene in the cervical exfoliated cells from natural population in Shenzhen].
    Li YB; Wulan N; Liu ZH; Li J; Wang C; Zhou YQ; Wu RF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Sep; 30(9):946-50. PubMed ID: 20193234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas.
    Andersson S; Wallin KL; Hellström AC; Morrison LE; Hjerpe A; Auer G; Ried T; Larsson C; Heselmeyer-Haddad K
    Br J Cancer; 2006 Aug; 95(3):331-8. PubMed ID: 16847471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human papillomavirus and human telomerase RNA component gene in cervical cancer progression.
    Liu Y; Fan P; Yang Y; Xu C; Huang Y; Li D; Qing Q; Sun C; Zhou H
    Sci Rep; 2019 Nov; 9(1):15926. PubMed ID: 31685833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of HPV DNA test value in management women with cytological findings of ASC-US, CIN1 and CIN2.
    Pajtler M; Milicić-Juhas V; Milojković M; Topolovec Z; Curzik D; Mihaljević I
    Coll Antropol; 2010 Mar; 34(1):81-6. PubMed ID: 20432737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of hTERC in thinprep samples with mild cytologic abnormality and HR-HPV positive.
    Li Y; Zeng WJ; Ye F; Wang XY; Lü WG; Ma D; Wei LH; Xie X
    Gynecol Oncol; 2011 Jan; 120(1):73-83. PubMed ID: 21035173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amplification of the telomerase RNA component gene as a new genetic marker for disease progression and prognosis in esophageal squamous cell carcinoma.
    Wang JD; Ma J; Wang FY; Peng LB; Wang X; Shi SS; Ma HH; Lu ZF; Lu GM; Zhou XJ
    Dis Esophagus; 2013; 26(7):737-45. PubMed ID: 23317107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of genetic copy number changes in cervical disease progression.
    Policht FA; Song M; Sitailo S; O'Hare A; Ashfaq R; Muller CY; Morrison LE; King W; Sokolova IA
    BMC Cancer; 2010 Aug; 10():432. PubMed ID: 20712890
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential DNA copy number aberrations in the progression of cervical lesions to invasive cervical carcinoma.
    Oh EK; Kim YW; Kim IW; Liu HB; Lee KH; Chun HJ; Park DC; Oh EJ; Lee AW; Bae SM; Ahn WS
    Int J Oncol; 2012 Dec; 41(6):2038-46. PubMed ID: 23023522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
    Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
    Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of fluorescence in situ hybridization and hybrid capture 2 analyses of cervical cytology specimens diagnosed as low grade squamous intraepithelial lesion for the detection of high grade cervical intraepithelial neoplasia.
    Voss JS; Kipp BR; Campion MB; Sokolova IA; Henry MR; Halling KC; Clayton AC
    Anal Quant Cytol Histol; 2010 Jun; 32(3):121-30. PubMed ID: 20701064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.